Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparing Approaches to Assess Nitric Oxide-dependent Cutaneous Vasodilation
NCT06499844Phase 1Active, not recruiting
- Sponsor
- University of Iowa
- Start
- Aug 2024
- Primary completion
- Aug 2025
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of acetylcholine, sponsored by University of Iowa. Primary endpoints: Microvascular blood flow response to acetylcholine at 4 hours, Microvascular blood flow response to local heat (42 degrees Celsius) at 4 hours and 1 more. Started Aug 2024; status: active, not recruiting.
02
Drugs
acetylcholine
Beyond the preview
Go deeper on NCT06499844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06499844.